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Figure S1. Structure of complex 6 in the solid state. 
 
 



































Figure S3. Structure of complex 17 in the solid state. 
 
 




























































Figure S5. Structure of the ate-complex complex 21 in the solid state. 
 
CCDC-973605 (21), CCDC-973606 (6), CCDC-973607 (10), CCDC-973608 (17), and CCDC-973609 (19) 
contain the supplementary crystallographic data for this paper. This information can be obtained free 
of charge from The Cambridge Crystallographic Data Centre via  
www.ccdc.cam.ac.uk/data_request/cif. 
 
X-ray Crystal Structure Analysis of Complex 6: C40 H54 Fe2 O, Mr = 662.53  g · mol
-1, red plate, crystal 
size 0.254 x 0.153 x 0.060 mm, monoclinic, space group C2/c, a =  18.8361(7) Å, b = 18.9509(6) Å, c = 
13.1715(6) Å, β = 128.927(6)°, V = 3657.7(2) Å3, T = 100 K, Z = 4, Dcalc = 1.203  g·cm
3,  = 0.71073 Å, 
(Mo-K) = 0.676 mm-1, Empirical absorption correction (Tmin = 0.71, Tmax = 0.91), Bruker-AXS Enraf-
Nonius KappaCCD diffractometer,  2.78 <  < 33.10°, 44987 measured reflections, 6945  independent 
reflections, 5942 reflections with I > 2(I), Structure solved by direct methods and refined by full-
matrix least-squares against F2 to R1 = 0.030 [I > 2(I)], wR2 =  0.076, 202 parameters, H atoms riding,  
S =  1.089, residual electron density 0.4 / -0.4 e Å-3.  
X-ray Crystal Structure Analysis of Complex 10: C28 H46 Fe P2, Mr = 500.44  g · mol
-1, yellow plate, 
crystal size 0.480 x 0.325 x 0.140 mm, orthorombic, space group Pbca, a =  17.901(2) Å, b = 
15.2534(17) Å, c = 20.199(2) Å, V = 5515.5(11) Å3, T = 100 K, Z = 8, Dcalc = 1.205  g·cm
3,  = 0.71073 Å, 
(Mo-K) = 3.441 mm-1, Empirical absorption correction (Tmin = 0.74, Tmax = 0.91), Bruker-AXS Enraf-
Nonius KappaCCD diffractometer,  2.02 <  < 36.32°, 203791 measured reflections, 13326 
independent reflections, 11800 reflections with I > 2(I), Structure solved by direct methods and 
refined by full-matrix least-squares against F2 to R1 = 0.025 [I > 2(I)], wR2 =  0.077, 290 parameters, H 
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atoms riding,  S =  1.076, absolute structure parameter = 0.026(7), residual electron density 0.6 / -0.3 
e Å-3.  
X-ray Crystal Structure Analysis of Complex 17: C40 H96 Cl4 Fe2 P8, Mr = 1078.43  g · mol
-1, green plate, 
crystal size 0.21 x 0.13 x 0.08 mm, triclinic, space group P1¯, a = 10.2085(12) Å, b = 16.3797(19)  Å, c = 
16.692(2) Å, α = 83.460(2)°, β = 88.817(2)°, γ = 78.306(2)°, V = 2715.4(6) Å3, T = 200 K, Z = 2, Dcalc = 
1.319  g·cm3,  = 0.71073 Å, (Mo-K) = 0.994 mm
-1, Gaussian absorption correction (Tmin = 0.80, Tmax 
= 0.92), Bruker-AXS Smart APEX-II diffractometer,  1.23 <  < 31.00°, 80063 measured reflections, 
17311 independent reflections, 14555 reflections with I > 2(I), Structure solved by direct methods 
and refined by full-matrix least-squares against F2 to R1 = 0.040 [I > 2(I)], wR2 =  0.121, 501 
parameters, H atoms riding,  S =  1.027, residual electron density 1.4 / -1.3 e Å-3. 
X-ray Crystal Structure Analysis of Complex 19: C56H106 Fe4 P4, Mr = 563.34  g · mol
-1, yellow block, 
crystal size 0.13 x 0.11 x 0.09 mm, triclinic, space group P1¯, a = 13.5165(17) Å, b = 15.0944(19) Å, c = 
17.563(2) Å, α = 84.612(2)°, β = 68.541(2)°, γ = 71.096(2)°, V = 3153.8(7) Å3, T = 100 K, Z = 2, Dcalc = 
1.186  g·cm3,  = 0.71073 Å, (Mo-K) = 1.034 mm
-1, Gaussian absorption correction (Tmin = 0.92, Tmax 
= 0.95), Bruker-AXS Smart APEX-II diffractometer,  1.43 <  < 34.34°, 109475 measured reflections, 
26318 independent reflections, 18331reflections with I > 2(I), Structure solved by direct methods 
and refined by full-matrix least-squares against F2 to R1 = 0.037 [I > 2(I)], wR2 =  0.091, 607 
parameters, H atoms riding,  S =  1.025, residual electron density 0.6 / -0.8 e Å-3. 
X-ray Crystal Structure Analysis of Complex 21: C51 H81 Br1.29 Cl1.71 Fe Mg2 O6  · 0.5 C7 H8, Mr = 1104.40 g 
· mol
-1, colorless plate, crystal size 0.239 x 0.157 x 0.062 mm, monoclinic, space group P21/n, a =  
13.546(2) Å, b = 15.160(3) Å, c = 28.029(5) Å, β = 96.233(3)°, V = 5721.8(18) Å3, T = 100 K, Z = 4, Dcalc = 
1.282  g·cm3,  = 0.71073 Å, (Mo-K) = 1.311 mm-1, Empirical absorption correction (Tmin = 0.85, Tmax 
= 0.96), Bruker-AXS Enraf-Nonius KappaCCD diffractometer,  1.46 <  < 27.13°, 122880 measured 
reflections, 12616 independent reflections, 7765 reflections with I > 2(I), Structure solved by direct 
methods and refined by full-matrix least-squares against F2 to R1 = 0.060 [I > 2(I)], wR2 =  0.166, 593 




General. All reactions were carried out in carefully flame-dried glassware under Argon. All solvents 
were dried and purified by distillation over the indicated drying agents and were transferred under 
Argon: THF (Mg-anthracene), diethyl ether (Mg-anthracene), dichloromethane (CaH2), acetonitrile 
(CaH2), triethylamine (CaH2), hexane (Na/K), toluene (Na/K). HOAc and MeOH were used as received. 
Flash chromatography: Merck silica gel 60 (230-400 mesh). IR: Nicolet FT-7199 spectrometer, 
wavenumbers in cm−1. MS (EI): Finnigan MAT 8200, MS (CI): Finnigan MAT 95, MS (ESI) ESQ 3000; 
accurate mass determinations: Bruker APEX III FT-MS (7 T magnet). NMR: Spectra were recorded on 
a Bruker DPX 300, AV 400 or AV 500 spectrometer in the solvents indicated; 1H and 13C chemical 
shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used 
as references (CDCl3: δH = 7.24 ppm, δC = 77.0 ppm) and the chemical shifts converted to the TMS 
scale. Elemental analyses: H. Kolbe, Mülheim/Ruhr. Unless stated otherwise, all commercially 
available compounds (Acros, Sigma-Aldrich, Fluka, Alfa Aesar, Lancaster, Strem) were used as 
received. 










4 and trans-[Fe[(EtO)3P]2(mes)2] (13),
4 and trans-[Fe(depe)2Cl2] 
(17); 5 complex [Fe(3,5-tBu-SciOPP)(mes)2] (14) was prepared analogously; since no crystals suitable 
for X-ray diffraction could be grown so far, the assignment remains tentative. 
Preparation of [FeCl2 · (THF)n] (5).
6 A Soxhlet apparatus was charged with anhydrous FeCl2 (10.0 g, 
78.7 mmol). The system was degassed in vacuum and refilled with argon. Anhydrous THF (160 mL) 
was added under argon atmosphere. The mixture was heated to reflux for three days to furnish a 
suspension of a pale-pink colored solid in a yellow solution. The solid was separated by filtration and 
dried under a stream of argon. The product was obtained as a pale-pink colored solid (17.3 g). 
Elemental analysis of different samples prepared according to this protocol showed a varying THF 
content in the range of  1.2  1.5 mol per mol of FeCl2. 
Preparation of Fe2Mes4 (6).
7 Freshly prepared [FeCl2 · 1.5 THF] (10.82 g, 46.0 mmol) was suspended 
in a mixture of anhydrous THF (200 mL) and 1,4-dioxane (40 mL). The suspension was cooled to 30 
oC before MesMgBr (0.88 M in THF, 104.5 mL, 92.0 mmol) was slowly introduced to the stirred 
suspension (with occasional shaking). The temperature was raised to room temperature and stirring 
continued for 2 h. For work up, the magnesium salts were filtered off under Ar and the filtrate was 
evaporated to dryness. The resulting residue was dried under vacuum before Et2O (200 mL) was 
added. A second filtration was performed to remove traces of remaining magnesium salts. The 
                                                          
1
  (a) M. Irwin, R. K. Jenkins, M. S. Denning, T. Krämer, F. Grandjean, G. J. Long, R. Herchel, J. E. McGrady, J. M. 
Goicoechea, Inorg. Chem. 2010, 49, 6160-6171; (b) C. P. Magill, C. Floriani, A. Chiesi-Villa, C. Rizzoli, Inorg. 
Chem. 1994, 33, 1928-1933. 
2
  T. Hatakeyama, T. Hashimoto, Y. Kondo, Y. Fujiwara, H. Seike, H. Takaya, Y. Tamada, T. Ono, M. Nakamura, 
J. Am. Chem. Soc. 2010, 132, 10674-10676. 
3
  K.-J. Lattermann, W. Seidel, Z. Chem. 1983, 23, 31. 
4
  E. J. Hawrelak, W. H. Bernskoetter, E. Lobkovsky, G. T. Yee, E. Bill, P. J. Chirik, Inorg. Chem. 2005, 44, 3103-
3111. 
5
  (a) M. di Vaira, S. Midollini, L. Sacconi, Inorg. Chem. 1981, 20, 3430-3435; (b) M. V. Baker, L. D. Field, T. W. 
Hambley, Inorg. Chem. 1988, 27, 2872-2876. 
6
  R. J. Kern, J. Inorg. Nucl. Chem. 1962, 24, 1105–1109. 
7
  A. Klose, E. Solari, R. Ferguson, C. Floriani, Organometallics 1993, 12, 2414-2416. 
S-7 
 
solution was slowly concentrated to a volume of ca. 40 mL, from which the product crystallized. The 
precipitate was filtered off and dried in vacuo to furnish complex 6 in form of a brick-red solid (12.04 
g, 89%). The structure and constitution was confirmed by X-ray diffraction (see above). 
Preparation of Fe(depe)Mes2 (10) from Fe(depe)2Cl2 (17). MesMgBr solution (1 M in THF, 0.344 mL, 
0.344 mmol) was slowly added via syringe to a strirred solution of Fe(depe)2Cl2 (17) (84.2 mg, 0.156 
mmol) in THF (3.0 mL). Once the addition was complete, the mixture was stirred at 70 oC for 30 min 
before it was allowed to cool to ambient temperature. The solvent was removed under vacuum and 
the residue was dissolved in cold Et2O (30 
oC). The precipitated magnesium salts were filtered off 
and the yellow filtrate was evaporated in vacuo. A small amount of cold pentane (about 0.5 mL, 30 
oC) was added and the mixture was stirred until a yellow suspension had formed. The solid was 
collected by filtration and dried under vacuum to give complex 10 as a yellow solid (63.2 mg, 81%). 
The structure was confirmed by X-ray diffraction (see above). 
Complex 19. MesMgBr (1 M in THF, 0.416 mL, 0.416 mmol) was added via syringe to a solution of  
[(1,3-bis(di-tert-butylphosphino)propane)FeCl2] (18, R = tBu) (191.1 mg, 0.416 mmol) in THF (5.0 mL). 
The mixture was stirred at ambient temperature for 3 h to form a yellow-brown solution. The solvent 
was removed in vacuo and the residue was suspended in cold Et2O (30 
oC). The precipitated 
magnesium salts were filtered off and washed with cold Et2O (30 
oC). The combined filtrates were 
evaporated to afford the title complex as a yellow-orange solid (118.2 mg, 53%). The structure was 
confirmed by X-ray diffraction (see above). 
Representative Procedure for the Stoichiometric Reaction of 1-Iodoundecane with Various Iron 
Complexes: Preparation of 1,3,5-Trimethyl-2-undecylbenzene (16). 1-Iodoundecane (44.6 mg, 0.158 
mmol) was added to a stirred solution of [Fe(depe)Mes2] (10) (102.9 mg, 0.206 
mmol) in THF (4.0 mL). The mixture was then stirred at 70 oC until complete 
conversion of the starting material was reached (the reaction was monitored by 
GC-MS; the samples were quenched with MeOD and then diluted by MeOtBu). For 
work up, the mixture was allowed to reach ambient temperature, the reaction was quenched with 
water (20 mL) and the organic phase extracted by MeOtBu (3 x 20 mL). The combined organic layers 
were dried over Na2SO4 and evaporated, and the residue purified by flash chromatography (silica, 
hexane) to give the title compound as a colorless liquid (39.4 mg, 91%). 1H NMR (400 MHz, CDCl3): δ 
= 1.02 (t, J = 3.6 Hz, 3H), 1.40-1.54 (m, 18H), 2.36 (s, 3H), 2.40 (s, 6H), 2.68 (t, J = 8.0 Hz, 2H), 6.93 (s, 
2H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 19.7, 20.8, 22.7, 29.4, 29.5, 29.6, 29.7, 30.3, 32.0, 128.9, 
134.7, 135.8, 136.7. IR (film, cm-1): 2921, 2853, 1614, 1578, 1484, 1466, 1376, 1205, 1117, 1029, 
1012, 849, 721. MS (EI): m/z (%) 274 (31), 133 (100), 120 (3), 105 (3), 91 (2), 55 (2), 41 (4). HRMS (EI): 
m/z: calcd for C20H34 [M]: 274.26618, found: 274.26605. 
Representative Procedure for the Iron-Catalyzed Cross-Coupling of Alkyl Halides with Aryl Grignard 
Reagents: Preparation of 1,3,5-Trimethyl-2-undecylbenzene (16). Method A: MesMgBr (1 M in THF, 
0.97 mL, 0.974 mmol) was added dropwise over 1 h to a stirred solution of 1-iodoundecane (228.9 
mg, 0.812 mmol) and [Fe(depe)Mes2] (20.3 mg,  5 mol%, 0.041 mmol) in THF (4 mL) at 70°C. Once the 
addition was complete, stirring was continued at this temperature for 30 min before the mixture was 
allowed to reach ambient temperature. The reaction was quenched with water (20 mL) and the 
organic phase extracted by MeOtBu (3 x 20 mL). The combined organic layers were dried over Na2SO4 
and evaporated, and the residue purified by flash chromatography (silica, hexane) to give the title 
compound as a colorless liquid (200.2 mg, 90%). The spectral data are identical with described above. 
Method B: MesMgBr (1 M in THF, 0.86 mL, 0.86 mmol) was added dropwise over 1 h to a stirred 
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solution of 1-undecyl tosylate (207.5 mg, 0.64 mmol), [Fe(depe)2Cl2]2 (17.2 mg,  0.032 mmol) and NaI 
(9.5 mg, 0.064 mmol) in THF (3 mL) at 70°C. Once the addition was complete, stirring was continued 
at this temperature until GC control indicated complete conversion of the substrate. The mixture was 
then allowed to reach ambient temperature before the reaction was quenched with water (20 mL). 
The organic phase was extracted by MeOtBu (3 x 20 mL), the combined organic layers were dried 
over Na2SO4 and evaporated, and the residue was purified by flash chromatography (silica, hexane) 
to give the title compound as a colorless liquid (175.2 mg, 99%). The spectral data are identical with 
those described above. 
The following compounds were prepared analogously: 
Compound 22. Colorless syrup (95%). 1H NMR (400 MHz, CDCl3): δ = 0.20 (s, 6H), 1.05 (s, 9H), 1.44-
1.68 (m, 18H), 2.38 (s, 3H), 2.42 (s, 6H), 2.70 (t, J = 7.6 Hz, 2H), 3.75 (t, J = 6.1 Hz, 
2H), 6.96 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = -5.3, 18.3, 19.7, 20.8, 25.8, 26.0, 
29.38, 29.46, 29.54, 29.59, 29.63, 29.7, 30.3, 32.9, 63.3, 128.8, 134.6, 135.7, 136.6. IR (film, cm-1): 
2925, 2854, 1717, 1614, 1578, 1470, 1463, 1387, 1360, 1253, 1097, 1030, 1006, 959, 938, 833, 773, 
719, 661. MS (EI): m/z (%) 404 (1), 347 (100), 199 (2), 159 (6), 133 (99), 115 (3), 89 (5), 75 (30), 59 (3), 
41 (3). HRMS (ESI+): m/z: calcd for C26H48OSiNa [M+Na]: 427.33636, found: 427.33666. 
Compound 23. Colorless syrup (94%). 1H NMR (400 MHz, CDCl3): δ = 1.30 (s, 9H), 1.39-1.57 (m, 16H), 
1.68-1.75 (m, 2H), 2.33 (s, 3H), 2.37 (s, 6H), 2.66 (t, J = 7.2 Hz, 2H), 4.15 (t, J = 6.0 Hz, 
2H), 6.91 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 19.6, 20.7, 25.8, 27.1, 28.5, 29.1, 
29.29, 29.35, 29.46, 29.52, 30.2, 38.6, 64.3, 128.7, 134.5, 135.6, 136.5, 178.4. IR (film, 
cm-1): 2924, 2854, 1728, 1614, 1578, 1480, 1460, 1397, 1365, 1283, 1151, 1033, 978, 939, 849, 770, 
722. MS (EI): m/z (%) 374 (35), 272 (6), 159 (1), 133 (100), 120 (6), 105 (2), 85 (2), 69 (1), 57 (15), 41 
(5). HRMS (EI): m/z: calcd for C25H42O2 [M]: 374.31865, found: 374.31848. 
Compound 24. Colorless syrup (67%). 1H NMR (400 MHz, CDCl3): δ = 1.53-1.81 (m, 4H), 1.85-1.91 (m, 
4H), 2.27 (s, 3H), 2.32 (s, 6H), 2.64-2.77 (m, 2H), 3.47-3.57 (m, 2H), 3.82-3.96 
(m, 2H), 4.65 (t, J = 3.7 Hz, 1H), 6.85 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 
19.6, 20.7, 25.5, 26.0, 29.4, 30.8, 62.3, 67.4, 98.8, 128.8, 134.8, 135.87, 135.95. 
IR (film, cm-1): 2942, 2868, 1614, 1577, 1485, 1465, 1452, 1377, 1352, 1322, 1260, 1200, 1187, 1156, 
1136, 1118, 1072, 1033, 1020, 988, 969, 906, 868, 849, 814, 718. MS (EI): m/z (%) 262 (14), 178 (19), 
160 (24), 145 (25), 133 (53), 119 (6), 105 (6), 91 (6), 85 (100), 67 (7), 57 (7), 41 (13), 29 (7). HRMS (EI): 
m/z: calcd for C17H26O2 [M]: 262.19310, found: 262.19328. 
Compound 25. Colorless syrup (86%). 1H NMR (400 MHz, CDCl3): δ = 1.47-1.51 (m, 6H), 1.65-1.72  (m, 
2H), 2.28 (s, 3H), 2.31 (s, 6H), 2.59 (t, J = 8.2 Hz, 2H), 3.51 (t, J = 6.8 Hz, 2H), 4.54 (s, 
2H), 6.86 (s, 2H), 7.29-7.38 (m, 5H). 13C NMR (100 MHz, CDCl3): δ = 19.7, 20.7, 26.1, 
29.3, 29.4, 29.8, 30.1, 70.4, 72.8, 127.4, 127.6, 128.3, 128.8, 134.7, 135.8, 136.5, 
138.7. IR (film, cm-1): 3850, 3735, 3672, 3650, 3030, 2934, 2856, 2343, 1719, 1614, 1578, 1484, 1454, 
1361, 1308, 1265, 1204, 1098, 1028, 908, 850, 804, 731, 696. MS (EI): m/z (%) 310 (18), 219 (8), 201 
(6), 159 (5), 133 (100), 121 (5), 99 (7), 91 (26), 81 (6), 41 (3). HRMS (EI): m/z: calcd for C22H30O [M]: 
310.22989, found: 310.22966. 
Compound 26. Colorless syrup (76%). 1H NMR (400 MHz, CDCl3): δ = 1.56-1.64 (m, 2H), 1.83-1.90 (m, 
2H), 2.15 (s, 3H), 2.20 (s, 6H), 2.57 (t, J = 8.5 Hz, 2H), 3.96 (t, J = 6.0 Hz, 2H), 
6.69-6.79 (m, 4H), 7.11-7.16 (m, 1H), 7.42-7.44 (m, 1H). 13C NMR (100 MHz, 
CDCl3): δ = 19.7, 20.8, 25.7, 29.0, 29.6, 68.7, 112.3, 113.1, 121.6, 128.4, 128.9, 
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133.3, 134.9, 135.8, 136.0, 155.4. IR (film, cm-1): 3063, 2945, 2873, 1613, 1587, 1573, 1482, 1466, 
1442, 1377, 1292, 1277, 1247, 1161, 1125, 1051, 1030, 984, 964, 924, 881, 851, 746, 708, 691, 665. 
MS (EI): m/z (%) 348 (11), 346 (12), 175 (71), 159 (4), 133 (100), 117 (6), 91 (7), 77 (3), 55 (3), 41 (4). 
HRMS (EI): m/z: calcd for C19H23OBr [M]: 346.09322, found: 346.09324. 
Compound 27. Colorless syrup (70%). 1H NMR (400 MHz, CDCl3): δ = 1.55-1.63 (m, 6H), 1.72-1.79 (m, 
2H), 2.35 (s, 3H), 2.38 (s, 6H), 2.40 (t, J = 7.0 Hz, 2H), 2.68 (t, J = 7.0 Hz, 2H), 6.92 (s, 
2H). 13C NMR (100 MHz, CDCl3): δ = 16.8, 19.5, 20.6, 25.2, 28.4, 28.9, 29.0, 29.1, 119.6,  
128.7, 134.6, 135.5, 136.0. IR (film, cm-1): 2935, 2857, 2246, 1733, 1613, 1578, 1484, 
1459, 1425, 1377, 1206, 1141, 1078, 1029, 1013, 851, 722. MS (EI): m/z (%) 229 (17), 133 (100), 117 
(3), 105 (3), 91 (4), 77 (2), 41 (4). HRMS (EI): m/z: calcd for C16H23N [M]: 229.18292, found: 
229.18305. 
Compound 28. Colorless syrup (59%). 1H NMR (400 MHz, CDCl3): δ = 0.69 (s, 3H), 1.70-1.77 (m, 2H), 
2.27 (s, 3H), 2.28 (s, 6H), 2.65-2.69 (m, 2H), 3.83 (t, J = 6.3 Hz, 2H), 6.85 (s, 2H), 
7.39-7.45 (m, 6H), 7.61-7.66 (m, 4H). 13C NMR (100 MHz, CDCl3): δ = 3.0, 19.6, 
20.8, 25.7, 32.1, 63.6, 127.8, 128.8, 129.8, 134.3, 134.8, 135.9, 136.0, 136.2. IR (film, cm-1): 3069, 
3048, 3001, 2949, 2918, 2865, 1974, 1956, 1884, 1827, 1614, 1590, 1485, 1468, 1428, 1379, 1303, 
1253, 1178, 1111, 1081, 1028, 1011, 998, 969, 914, 849, 818, 788, 766, 729, 696, 655. MS (EI): m/z 
(%) 374 (26), 296 (12), 197 (27), 183 (11), 160 (100), 145 (61), 133 (50), 117 (8), 105 (9), 91 (14), 77 
(7), 41 (4). HRMS (EI): m/z: calcd for C25H30OSi [M]: 374.20627, found: 374.20659. 
Compound 29. Colorless syrup (80%). 1H NMR (400 MHz, CDCl3): δ = 1.11 (t, J = 7.4 Hz, 3H), 1.35 (s, 
9H), 1.66-1.77 (m, 6H), 1.82-1.87 (m, 1H), 2.50 (s, 3H), 2.52 (s, 6H), 2.82 (t, J 
= 2.7 Hz, 2H), 3.85-3.86 (m, 2H), 7.08 (s, 2H), 7.58-7.66 (m, 6H), 7.94-7.96 
(m, 4H). 13C NMR (100 MHz, CDCl3): δ = 11.3, 19.4, 19.7, 20.9, 23.7, 26.7, 
27.0, 29.9, 31.2, 42.0, 65.7, 127.6, 128.8, 129.5, 134.1, 134.6, 135.6, 135.7, 136.5. IR (film, cm-1): 
3071, 3050, 3000, 2957, 2930, 2857, 1900, 1825, 1614, 1589, 1484, 1471, 1462, 1427, 1389, 1377, 
1361, 1306, 1260, 1187, 1106, 1029, 1007, 998, 970, 938, 908, 850, 823, 793, 736, 699, 689. MS (EI): 
m/z (%) 415 (74), 215 (5), 199 (58), 183 (11), 159 (10), 133 (100), 91 (5), 77 (6), 57 (4), 41 (6). HRMS 
(ESI+): m/z: calcd for C32H44OSiNa [M+Na]: 495.30520, found: 495.30536. 
Compound 30. Colorless syrup (81%). 1H NMR (400 MHz, CDCl3): δ = 2.19-2.28 (m, 2H), 2.33 (s, 3H), 
2.37 (s, 6H), 2.98 (t, J = 2.7 Hz, 2H), 6.94 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 
19.3, 19.8 (t, J = 16.6 Hz), 20.7, 30.5 (t, J = 90.4 Hz), 105-125 (m), 129.3, 132.7, 
136.1, 136.2. IR (film, cm-1): 2975, 2926, 1615, 1581, 1486, 1472, 1451, 1365, 1317, 1233, 1188, 1142, 
1119, 1070, 1027, 979, 945, 903, 853, 807, 778, 746, 736, 722, 706, 692. MS (EI): m/z (%) 466 (29), 
447 (5), 133 (100), 119 (6), 91 (5), 69 (7). HRMS (EI): m/z: calcd for C17H15F13 [M]: 466.09643, found: 
466.09662. 
Compound 31. Colorless syrup (58%). 1H NMR (400 MHz, CDCl3): δ = 0.06 (s, 9H), 2.14 (s, 2H), 2.23 (s, 
6H), 2.27 (s, 3H), 6.84 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = -0.1, 19.6, 20.7, 21.1, 128.6, 
132.7, 134.6, 134.8. IR (film, cm-1): 2953, 2917, 2731, 1723, 1613, 1575, 1480, 1445, 
1417, 1375, 1289, 1248, 1206, 1164, 1027, 1011, 922, 838, 782, 760, 726, 690, 662. MS 
(EI): m/z (%) 206 (28), 191 (5), 175 (5), 133 (7), 117 (3), 105 (2), 91 (4), 73 (100), 59 (3), 45 (6). HRMS 




Compound 32. Colorless syrup (72%). 1H NMR (400 MHz, CDCl3): δ = 0.98 (s, 9H), 2.27 (s, 3H), 2.32 (s, 
6H), 2.66 (s, 2H), 6.86 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 20.7, 21.6, 30.6, 34.7, 40.7, 
126.9, 129.0, 134.1, 134.5, 137.7. IR (film, cm-1): 2949, 2867, 1725, 1613, 1477, 1391, 
1376, 1362, 1230, 1199, 1156, 1033, 850, 790, 751, 697, 583, 564, 515, 468. MS (EI): m/z 
(%) 190 (19), 175 (4), 133 (100), 119 (19), 105 (5), 91 (7), 77 (4), 57 (10), 41 (6). HRMS (EI): m/z: calcd 
for C14H22 [M]: 190.17198, found: 190.17215. 
Compound 33. Colorless syrup (55%). 1H NMR (400 MHz, CDCl3): δ = 0.92 (s, 9H), 2.57 (s, 2H), 3.80 (s, 
3H), 6.85-6.90 (m, 2H), 7.08-7.10 (m, 1H), 7.17-7.21 (m, 1H). 13C NMR (100 MHz, 
CDCl3): δ = 29.5, 32.4, 42.7, 55.0, 110.3, 119.7, 127.0, 128.4, 132.4, 158.1. IR (film, 
cm1): 2949, 2905, 2865, 2835, 1600, 1585, 1493, 1462, 1438, 1392, 1363, 1330, 
1290, 1240, 1202, 1178, 1153, 1107, 1053, 1036, 930, 906, 833, 744, 709, 611, 572, 
537, 482, 435. MS (EI): m/z (%) 178 (33), 163 (10), 135 (5), 122 (100), 115 (4), 107 (10), 91 (51), 77 
(11), 65 (11), 57 (29), 51 (6), 41 (16), 29 (13). HRMS (EI): m/z: calcd for C12H18O [M]: 178.13566, 
found: 178.13577. 
Compound 34. Colorless oily liquid (77%). 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 6.2 Hz, 3H), 1.28-
1.42 (m, 18H), 1.53-1.62 (m, 2H), 2.32 (s, 3H), 2.60 (t, J = 7.7 Hz, 2H), 7.08-7.15 (m, 
4H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 19.3, 22.7, 29.4, 29.57, 29.63, 29.65, 29.68, 
29.73, 30.3, 31.9, 33.3, 125.7, 125.8, 128.8, 130.1, 135.8, 141.1. IR (film, cm-1): 2922, 
2852, 1604, 1493, 1463, 1378, 739, 450. MS (EI): m/z (%) 260 (33), 118 (3), 105 (100), 
91 (9), 79 (5), 57 (6), 43 (13), 29 (9). HRMS (EI): m/z: calcd for C19H32 [M]: 260.25038, found: 
260.25040. 
Compound 35. Colorless syrup (70%). 1H NMR (400 MHz, CDCl3): δ = 0.89 (t, J = 6.7 Hz, 3H), 1.27-1.37 
(m, 18H), 1.55-1.62 (m, 2H), 2.61 (t, J = 7.6 Hz, 2H), 3.83 (s, 3H), 6.84-6.90 (m, 2H), 
7.13-7.19 (m, 2H). 13C NMR (100 MHz, CDCl3): δ = 14.1, 22.7, 29.4, 29.55, 29.63, 
29.65, 29.70, 29.87, 30.1, 31.9, 55.2, 110.2, 120.3, 126.7, 129.7, 131.4, 157.5. IR 
(film, cm-1): 2922, 2852, 1601, 1588, 1493, 1464, 1438, 1377, 1326, 1289, 1241, 
1176, 1128, 1104, 1051, 1033, 742, 730, 569, 465. MS (EI): m/z (%) 276 (44), 121 (100), 108 (4), 91 
(42), 77 (4), 65 (4), 55 (5), 43 (17), 41 (17), 29 (14). HRMS (EI): m/z: calcd for C19H32O [M]: 276.24507, 
found: 276.24532. 
Compound 36. Colorless syrup (78% (GC); because of the low polarity of the compound, trace 
impurities had to be removed by HPLC). 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 6.1 
Hz, 3H), 1.29-1.41 (m, 14H), 1.48-1.55 (m, 2H), 1.60-1.68 (m, 2H), 2.51 (s, 3H), 3.06 (t, 
J = 7.2 Hz, 2H), 7.30 (d, J = 8.5 Hz, 1H), 7.39-7.42 (m, 1H), 7.47-7.51 (m, 1H), 7.62 (d, J 
= 8.2 Hz, 1H), 7.80 (d, J = 7.7 Hz, 1H), 8.03 (d, J = 8.5 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ = 14.1, 20.1, 22.7, 28.8, 29.3, 29.58, 29.65, 29.69, 30.1, 30.3, 31.9, 123.7, 124.4, 125.7, 
125.8, 128.5, 129.2, 132.1, 132.58, 132.63, 136.2. IR (film, cm-1): 2930, 2858, 1282, 1174, 1100, 744, 
563. MS (EI): m/z (%) 296 (59), 167 (3), 155 (100), 129 (3), 115 (3), 41 (4). HRMS (EI): m/z: calcd for 
C22H32 [M]: 296.25029, found: 296.25040. 
Compound 37. Colorless syrup (78%). 1H NMR (400 MHz, CDCl3): δ = 1.33-1.83 (m, 6H), 2.26 (s, 3H), 
2.32 (s, 6H), 2.26-2.91 (m, 2H), 3.35-3.47 (m, 2H), 3.95-3.99 (m, 1H), 6.84 (s, 2H). 13C 
NMR (100 MHz, CDCl3): δ = 20.5, 20.8, 23.8, 26.1, 32.0, 36.3, 68.7, 78.4, 128.9, 132.8, 
135.3, 137.0. IR (film, cm-1): 2934, 2844, 2737, 1957, 1614, 1577, 1484, 1440, 1377, 
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1365, 1350, 1286, 1261, 1219, 1195, 1173, 1086, 1067, 1045, 979, 946, 901, 849, 825, 800, 774, 732. 
MS (EI): m/z (%) 218 (12), 134 (22), 117 (4), 105 (3), 85 (100), 67 (12), 57 (12), 43 (13), 41 (11), 29 (8). 
HRMS (EI): m/z: calcd for C15H22O [M]: 218.16691, found: 218.16707. 
Compound 38. Colorless syrup (80%). 1H NMR (400 MHz, CDCl3): δ = 1.32 (s, 3H), 1.39 (s, 3H), 1.47 (s, 
3H), 1.57 (s, 3H), 2.28 (s, 3H), 2.39 (s, 6H), 2.95-3.00 (m, 1H), 3.07-3.12 (m, 1H), 
3.95 (t, J = 7.3 Hz, 1H), 4.09 (dd, J = 8.0, 1.4 Hz, 1H), 4.27 (dd, J = 5.0, 2.0 Hz, 1H), 
4.55 (dd, J = 8.0, 2.0 Hz, 1H), 5.57 (d, J = 4.3 Hz, 1H), 6.87 (s, 2H). 13C NMR (100 
MHz, CDCl3): δ = 20.1, 20.7, 24.2, 24.7, 26.0, 26.1, 30.0, 67.6, 70.7, 70.9, 71.8, 
96.6, 107.9, 108.7, 128.9, 131.8, 135.3, 137.1. IR (film, cm-1): 2986, 2918, 2732, 
1732, 1614, 1578, 1485, 1456, 1380, 1371, 1310, 1254, 1209, 1166, 1142, 1101, 1066, 1037, 1019, 
996, 956, 917, 901, 883, 864, 849, 807, 756, 733, 677. MS (EI): m/z (%) 362 (33), 347 (14), 229 (17), 
171 (46), 133 (70), 113 (8), 100 (10), 85 (9), 81 (9), 71 (100), 59 (16), 43 31). HRMS (ESI+): m/z: calcd 
for C21H30O5Na [M+Na]: 385.19848, found: 385.19854. 
Compound 39. Colorless syrup (89%). For analytical purposes, the two anomers were separated by 
HPLC: major anomer: 1H NMR (400 MHz, CDCl3): δ = 0.04 (s, 3H), 0.07 (s, 3H), 
0.09 (s, 3H), 0.10 (s, 3H), 0.88 (s, 9H), 0.92 (s, 9H), 2.24 (s, 3H), 2.31 (s, 6H), 2.82-
2.95 (m, 2H), 3.20 (s, 3H), 3.79-3.82 (m, 1H), 3.96-4.02 (m, 2H), 4.66 (d, J = 1.6 Hz, 
1H), 6.82 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = -4.8, -4.61, -4.58, -4.2, 17.8, 18.0, 
20.4, 20.8, 25.7, 25.9, 32.9, 54.8, 83.1, 83.3, 84.2, 109.2, 128.8, 132.8, 135.2, 136.9. IR (film, cm-1): 
2954, 2929, 2858, 1614, 1485, 1472, 1463, 1408, 1388, 1362, 1321, 1251, 1189, 1105, 1081, 1044, 
1006, 954, 917, 837, 776, 670; MS (EI): m/z (%) 463 (2), 437 (21), 405 (4), 377 (5), 331 (46), 301 (42), 
275 (9), 231 (4), 201 (9), 171 (9), 147 (9), 133 (100), 89 (28), 73 (76), 57 (14), 41 (7). HRMS (ESI+): m/z: 
calcd for C27H50O4Si2Na [M+Na]: 517.31420, found: 517.31399; minor anomer: 
1H NMR (400 MHz, 
CDCl3): δ = 0.08 (s, 3H), 0.09 (s, 3H), 0.10 (s, 3H), 0.13 (s, 3H), 0.91 (s, 9H), 0.93 (s, 9H), 2.23 (s, 3H), 
2.33 (s, 6H), 2.86-2.98 (m, 2H), 3.45 (s, 3H), 3.84-3.89 (m, 1H), 3.97 (dd, J = 7.0, 4.5 Hz, 1H), 4.07 (t, J = 
7.0 Hz, 1H), 4.65 (d, J = 4.4 Hz, 1H), 6.83 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = -4.53, -4.49, -4.37, -
3.8, 17.8, 18.2, 20.4, 20.8, 25.8, 26.0, 34.0, 56.1, 78.3, 79.8, 81.4, 103.1, 129.0, 132.5, 135.5, 136.7. IR 
(film, cm-1): 2953, 2928, 2857, 1614, 1578, 1472, 1463, 1445, 1407, 1388, 1374, 1361, 1331, 1250, 
1226, 1189, 1165, 1146, 1100, 1084, 1047, 1003, 939, 918, 895, 836, 776, 739, 721, 671. 
Compound 40. White solid (77%). 1H NMR (400 MHz, CDCl3): δ = 1.21 (s, 3H), 1.80-1.90 (m, 2H), 2.08 
(s, 3H), 2.14 (s, 3H), 2.19 (s, 3H), 2.26 (s, 3H), 2.39 (s, 6H), 2.60-2.66 (m, 2H), 
3.11 (d, J = 3.2 Hz, 2H), 3.63 (s, 3H), 6.86 (s, 2H). 13C NMR (100 MHz, CDCl3): 
δ = 11.6, 12.2, 12.6, 20.7, 20.8, 21.5, 23.4, 32.0, 40.2, 53.4, 60.4, 117.4, 
123.1, 125.7, 127.9, 128.9, 132.0, 135.3, 138.0, 147.7, 149.5. IR (film, cm-1): 
3747, 3651, 2978, 2938, 2915, 2824, 2730, 1724, 1611, 1573, 1455, 1398, 
1376, 1347, 1327, 1304, 1253, 1205, 1188, 1162, 1116, 1097, 1086, 1059, 1034, 1007, 988, 924, 864, 
849, 812, 789, 762, 744, 720, 680, 670. MS (EI): m/z (%) 352 (12), 219 (100), 179 (7), 133 (8), 105 (3), 
91 (4), 43 (5). HRMS (EI): m/z: calcd for C24H32O2 [M]: 352.23997, found: 352.24023. 
Compound 41. An extended reaction time (20 h) and 1.5 equiv. of the Grignard reagent were used to 
form this product as a pale yellow syrup (62%). 1H NMR (400 MHz, CDCl3): δ 
= 1.21 (s, 3H), 1.75-1.94 (m, 2H), 2.08 (s, 3H), 2.15 (s, 3H), 2.19 (s, 3H), 2.51-
2.74 (m, 2H), 3.00-3.13 (m, 2H), 3.64 (s, 3H), 3.75 (s, 6H), 6.53 (d, J = 8.3 Hz, 
2H), 7.16 (t, J = 8.3 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ = 11.66, 11.73, 
12.5, 20.7, 23.9, 31.2, 32.8, 55.2, 60.4, 76.6, 103.2, 114.6, 117.4, 112.9, 
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125.5, 127.3, 127.4, 148.3, 149.1, 159.2. IR (film, cm-1): 2934, 2835, 1593, 1473, 1457, 1403, 1376, 
1332, 1280, 1251, 1188, 1172, 1140, 1120, 1104, 1086, 1061, 1040, 1013, 909, 857, 803, 782, 730, 
702, 681, 648, 615, 587. MS (ESI+): m/z (%) 393.2 (100). HRMS (ESI+): m/z: calcd for C23H30O4Na 
[M+Na]+: 393.20347, found: 393.20363. 
Compound 42. Colorless syrup (88%). 1H NMR (400 MHz, CDCl3): δ = 1.21 (s, 9H), 1.27-1.37 (m, 20H), 
1.44-1.51 (m, 2H), 1.59-1.66 (m, 2H), 2.54 (t, J = 7.5 Hz, 2H), 4.06 (t, J = 6.5 
Hz, 2H), 6.44 (d, J = 8.4 Hz, 2H), 7.02 (t, J = 8.4 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ = 22.8, 25.9, 27.2, 28.6, 29.2, 29.5, 29.56, 29.58, 29.79, 38.7, 55.6, 
64.4, 103.7, 119.7, 126.3, 158.3, 178.6. IR (film, cm-1): 2925, 2854, 1726, 
1594, 1473, 1435, 1397, 1365, 1328, 1282, 1254, 1151, 1126, 1091, 1041, 979, 939, 773, 723, 698, 
589. MS (EI): m/z (%) 392 (25), 290 (3), 151 (100), 138 (3), 121 (5), 91 (13), 85 (3), 57 (20), 41 (7). 
HRMS (ESI+): m/z: calcd for C24H40O4Na [M+Na]
+: 415.28167, found: 415.28188. 
Compound 43. Colorless syrup (85%). 1H NMR (400 MHz, CDCl3): δ = 1.21 (s, 9H), 1.29-1.47 (m, 16H), 
1.59-1.66 (m, 2H), 2.29 (s, 3H), 2.55 (t, J = 7.4 Hz, 2H), 3.78 (s, 6H), 
4.06 (t, J = 6.7 Hz, 2H), 6.32 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 
25.7, 25.9, 27.2, 28.6, 29.2, 29.48, 29.51, 29.53, 29.57, 29.90, 38.7, 
55.1, 55.4, 64.4, 96.0, 106.4, 122.4, 137.6, 158.0, 158.4, 178.6. IR (film, 
cm-1): 2924, 2853, 1727, 1606, 1590, 1492, 1480, 1463, 1419, 1342, 1315, 1284, 1201, 1146, 1123, 
1085, 1062, 1035, 1005, 952, 827. MS (EI): m/z (%) 406 (29), 304 (3), 165 (100), 135 (12), 85 (3), 57 
(15), 41 (5). HRMS (ESI+): m/z: calcd for C25H42O4Na [M+Na]
+: 429.29731, found: 429.29753. 
Compound 44. Colorless syrup (83%). 1H NMR (400 MHz, CDCl3): δ = 1.22 (s, 9H), 1.25 (t, J = 7.3 Hz, 
6H), 1.29-1.35 (m, 12H), 1.38-1.52 (m, 4H), 1.61-1.68 (m, 2H), 2.61-2.68 (m, 
2H), 2.67 (q, J = 7.7 Hz, 4H), 4.07 (t, J = 6.6 Hz, 2H), 7.01-7.13 (m, 3H). 13C 
NMR (100 MHz, CDCl3): δ = 15.7, 25.8, 25.9, 27.2, 28.6, 29.2, 29.45, 29.49, 
29.51, 29.56, 30.4, 31.1, 38.7, 64.4, 125.8, 126.1, 138.3, 142.0, 178.6. IR 
(film, cm-1): 2963, 2925, 2854, 1729, 1479, 1459, 1397, 1365, 1283, 1151, 1059, 1035, 977, 939, 799, 
770, 751, 722. MS (EI): m/z (%) 388 (22), 286 (8), 257 (8), 173 (4), 159 (11), 147 (100), 133 (41), 131 
(12), 119 (54), 117 (19), 105 (13), 103 (12), 91 (14), 85 (15), 57 (92), 55 (13), 41 (32), 29 (15). HRMS 
(ESI+): m/z: calcd for C26H44O2Na [M+Na]
+: 411.32322, found: 411.32335. 
Compound 46. Colorless syrup (73%). 1H NMR (400 MHz, CDCl3): δ = 1.09 (d, J = 6.7 Hz, 3H), 1.54-1.60 
(m, 2H), 2.20-2.26 (m, 1H), 2.28 (s, 3H), 2.32 (s, 3H), 2.50-2.64 (m, 2H), 4.99-
5.08 (m, 2H), 5.75-5.84 (m, 1H), 6.93 (d, J = 7.6 Hz, 1H), 6.97 (s, 1H), 7.04 (d, J = 
7.7 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ = 18.7, 20.2, 20.9, 31.0, 37.3, 38.0, 
112.9, 126.4, 129.6, 130.0, 132.6, 135.2, 140.8, 144.4. IR (film, cm-1): 3078, 
2956, 2923, 2866, 1828, 1751, 1638, 1616, 1504, 1455, 1418, 1374, 1156, 1037, 994, 909, 879, 805, 
714, 679. MS (EI): m/z (%) 188 (55), 173 (4), 159 (2), 145 (3), 132 (28), 119 (100), 105 (37), 91 (25), 77 
(12), 65 (5), 53 (5), 41 (15), 27 (7). HRMS (EI): m/z: calcd for C14H20 [M]: 188.15636, found: 188.15650. 
Compound 52. Colorless syrup (53%). 1H NMR (400 MHz, CDCl3): δ = 1.34-1.45 (m, 4H), 2.00-2.05 (m, 
2H), 2.14 (s, 3H), 2.18 (s, 6H), 2.48 (t, J = 8.8 Hz, 2H), 4.84-4.95 (m, 2H), 5.68-5.78 
(m, 1H), 6.72 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 19.7, 20.7, 28.8, 29.2, 29.4, 
33.6, 114.4, 128.8, 134.7, 135.8, 136.4, 138.8. IR (film, cm-1): 3076, 2920, 2857, 2731, 1823, 1728, 
1640, 1614, 1579, 1484, 1468, 1455, 1376, 1255, 1206, 1176, 1108, 1071, 1029, 1012, 991, 908, 849, 
723, 627. MS (EI): m/z (%) 202 (28), 159 (6), 147 (4), 133 (100), 120 (12), 105 (5), 91 (7), 82 (7), 41 (5). 
HRMS (EI): m/z: calcd for C15H22 [M]: 202.17206, found: 202.17215. 
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Compound 53. Colorless syrup (16%). 1H NMR (400 MHz, CDCl3): δ = 1.26-1.32 (m, 2H), 1.54-1.57 (m, 
2H), 1.68-1.77 (m, 4H), 2.01-2.09 (m, 1H), 2.29 (s, 3H), 2.34 (s, 6H), 2.67 (d, J = 7.2 Hz, 
2H), 6.87 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 20.4, 20.8, 24.7, 32.9, 34.3, 41.4, 
128.9, 134.6, 136.2, 136.3. IR (film, cm-1): 2949, 2866, 1733, 1614, 1578, 1482, 1452, 
1376, 1205, 1143, 1028, 1012, 850, 721. MS (EI): m/z (%) 202 (17), 145 (2), 133 (100), 117 (6), 105 (7), 
91 (8), 77 (4), 41 (12). HRMS (EI): m/z: calcd for C15H22 [M]: 202.17197, found: 202.17215. 
Compound 55. Colorless syrup (64%). 1H NMR (400 MHz, CDCl3): δ = 2.27-2.39 (m, 2H), 2.35 (s, 3H), 
2.39 (s, 6H), 2.76-2.80 (m, 2H), 5.08-5.12 (m, 1H), 5.16-5.22 (m, 1H), 5.98-6.08 (m, 1H), 
6.93 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 19.7, 20.8, 28.9, 33.3, 114.5, 128.9, 135.0, 
135.6, 135.9, 138.5. MS (EI): m/z (%) 174 (13), 133 (100), 117 (5), 115 (5), 105 (4), 91 (6), 77 (3), 41 
(4). HRMS (EI): m/z: calcd for C13H18 [M]: 174.14100, found: 174.14085. 
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